Cancer

INDICATION: Myelomonocytic leukemia; B cell lymphoma; lung cancer

In vitro, cell culture and patient sample studies identified a SHP-2 inhibitor that could help treat myelomonocytic leukemia, B cell

Read the full 270 word article

User Sign In